NextPlat Corp (NASDAQ: NXPL, NXPLW) has announced an agreement to acquire an independent pharmacy in a rural community near Pensacola, Florida, for $1.5 million in cash, with the transaction expected to close during the fourth quarter of 2026, subject to customary closing conditions. The acquisition will expand the company's PharmcoRx retail footprint into an underserved market, where it plans to introduce same-day delivery, online fulfillment and higher-margin contracted services, including support for healthcare providers participating in the federal 340B Drug Pricing Program, long-term care facilities and government agencies.
The pharmacy generated approximately $5.6 million in sales during 2025 with retail margins of about 19% and operated profitably with positive working capital and no debt. NextPlat said the acquisition supports its strategy of expanding healthcare operations through rural pharmacy acquisitions, building on PharmcoRx's existing network of four specialty pharmacies in Florida and the healthcare segment's $39.7 million contribution to the company's $54.3 million in 2025 revenue.
This acquisition is significant for several reasons. It underscores NextPlat's commitment to expanding its healthcare footprint in underserved rural areas, where access to pharmacy services can be limited. By introducing services like same-day delivery and online fulfillment, the company aims to enhance patient convenience and adherence to medication regimens. Additionally, the focus on higher-margin contracted services, particularly the 340B Drug Pricing Program, positions NextPlat to capture additional revenue streams while supporting healthcare providers in serving low-income and uninsured patients.
The transaction also highlights the strategic importance of the healthcare segment for NextPlat, which contributed approximately 73% of the company's total revenue in 2025. With this acquisition, NextPlat continues to execute its growth strategy through targeted acquisitions of profitable, debt-free pharmacies in rural markets. The acquired pharmacy's strong financial performance—$5.6 million in sales with 19% retail margins—suggests the potential for accretive earnings and cash flow generation.
For investors, this move signals NextPlat's focus on building a scalable and profitable pharmacy network, leveraging its existing infrastructure and expertise in healthcare data management through its subsidiary Progressive Care. The company's ability to integrate acquisitions and drive operational efficiencies could enhance shareholder value over time.
To view the full press release, visit https://nnw.fm/8bVkW.
